OpenURL Connection Search

Select item for more details and to access through your institution.

Letter: which patient profile for tacrolimus in ulcerative colitis?
Published in:
Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 11, p. 1242, doi. 10.1111/apt.13598
By:
- Laharie, D.;
- Poullenot, F.
Publication type:
Article
Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study.
Published in:
Journal of Crohn's & Colitis, 2022, v. 16, n. 10, p. 1523, doi. 10.1093/ecco-jcc/jjac061
By:
- Poullenot, F;
- Amiot, A;
- Nachury, M;
- Viennot, S;
- Altwegg, R;
- Bouhnik, Y;
- Abitbol, V;
- Nancey, S;
- Vuitton, L;
- Peyrin-Biroulet, L;
- Biron, A;
- Fumery, M;
- Picon, L;
- Vidon, M;
- Reenaers, C;
- Serrero, M;
- Savoye, G;
- Beaugerie, L;
- Rivière, P;
- Laharie, D
Publication type:
Article
Frequency of and Factors Associated With Sexual Dysfunction in Patients With Inflammatory Bowel Disease.
Published in:
Journal of Crohn's & Colitis, 2017, v. 11, n. 11, p. 1347, doi. 10.1093/ecco-jcc/jjx100
By:
- Rivière, P.;
- Zallot, C.;
- Desobry, P.;
- Sabaté, J. M.;
- Vergniol, J.;
- Zerbib, F.;
- Peyrin-Biroulet, L.;
- Laharie, D.;
- Poullenot, F.
Publication type:
Article
Association Between Infliximab Trough Levels and the Occurrence of Paradoxical Manifestations in Patients with Inflammatory Bowel Disease: a Case-Control Study.
Published in:
Journal of Crohn's & Colitis, 2015, v. 9, n. 11, p. 982, doi. 10.1093/ecco-jcc/jjv159
By:
- Coutzac, C.;
- Chapuis, J.;
- Poullenot, F.;
- Chabrun, E.;
- Capdepont, M.;
- Blanco, P.;
- Laharie, D.
Publication type:
Article

Found: 4

Letter: which patient profile for tacrolimus in ulcerative colitis?

Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study.

Frequency of and Factors Associated With Sexual Dysfunction in Patients With Inflammatory Bowel Disease.

Association Between Infliximab Trough Levels and the Occurrence of Paradoxical Manifestations in Patients with Inflammatory Bowel Disease: a Case-Control Study.